Thus, our study reveals a new cooperative regulatory mechanism by which SP1/3 mediates ELK4 transcriptional activity in a noncanonical SP1/3‐dependent manner, emphasizing that the ELK4‐SP1/3 complex could be a potential therapeutic target for CRC. Here, ELK4 is linked to colorectal carcinoma.